NAGE
Niagen Bioscience, Inc.
3.10$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.48 | 0.60 | 0.47 | 0.36 | 0.36 | 0.30 | 0.43 | 0.50 | 0.58 | 0.48 | 0.57 | 0.81 | 0.97 | 1.00 | 1.03 | 1.11 | 1.25 | 1.51 | |
| – | 0.35 | 0.39 | 0.29 | 0.25 | 0.29 | 0.21 | 0.28 | 0.29 | 0.30 | 0.24 | 0.28 | 0.36 | 0.39 | 0.39 | 0.42 | 0.44 | 0.48 | 0.54 | |
| – | 0.13 | 0.21 | 0.18 | 0.11 | 0.07 | 0.09 | 0.15 | 0.21 | 0.28 | 0.23 | 0.29 | 0.45 | 0.58 | 0.62 | 0.61 | 0.68 | 0.77 | 0.97 | |
| – | – | – | – | – | – | 0.00 | 0.01 | 0.02 | 0.07 | 0.09 | 0.10 | 0.08 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.07 | |
| – | 0.27 | 0.22 | 0.24 | 0.34 | 0.26 | 0.15 | 0.22 | 0.20 | 0.25 | 0.40 | 0.49 | 0.60 | 0.50 | 0.54 | 0.41 | 0.33 | 0.23 | 0.32 | |
| 0.01 | 0.35 | 0.31 | 0.31 | 0.45 | 0.43 | 0.23 | 0.30 | 0.27 | 0.36 | 0.60 | 0.89 | 1.00 | 0.90 | 1.02 | 0.88 | 0.75 | 0.68 | 0.81 | |
| -0.01 | -0.22 | -0.09 | -0.13 | -0.35 | -0.36 | -0.13 | -0.15 | -0.06 | -0.08 | -0.37 | -0.60 | -0.55 | -0.33 | -0.40 | -0.27 | -0.07 | 0.10 | 0.17 | |
| – | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | – | – | – | – | |
| – | – | – | – | -0.35 | -0.36 | -0.13 | -0.15 | -0.07 | -0.10 | -0.37 | -0.61 | -0.56 | -0.33 | -0.40 | -0.24 | -0.07 | 0.11 | 0.21 | |
| 0.01 | 0.22 | 0.09 | 0.13 | – | – | – | – | 0.00 | – | – | – | – | – | – | – | – | 0.00 | 0.01 | |
| -0.01 | -0.22 | -0.09 | -0.13 | -0.35 | -0.36 | -0.13 | -0.15 | -0.08 | -0.08 | -0.26 | -0.61 | -0.56 | -0.33 | -0.40 | -0.24 | -0.07 | 0.11 | 0.20 | |
| -0.01 | -0.18 | -0.05 | -0.10 | -0.33 | -0.35 | -0.12 | -0.14 | -0.05 | -0.07 | -0.35 | -0.59 | -0.52 | -0.30 | -0.38 | -0.21 | -0.04 | 0.13 | 0.23 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.